Our results reveal a diametrically opposed role for Smad4 inactivation in sustaining liver and lung metastases and establish a critical interplay between driver mutations and organ-biased chromatin states that contributes to the heterogeneity of cancers driven by identical genetic lesions. The gene discussed is SMAD4; the disease is cancer.